Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...
Discoverer of Klotho gene further strengths KLTO Scientific Advisory BoardNEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and ...
(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease.
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological ...
We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...
Exploiting the remarkable capability of viruses to transport gene therapies past what until now has been a circulatory ...
Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise ...
The world’s largest genetic study on the size of specific brain parts has revealed hundreds of clues about how some health ...